STOCK TITAN

Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Viatris (NASDAQ: VTRS) is set to announce its Q2 2024 financial results on August 8, 2024, before the U.S. market opens. CEO Scott A. Smith and other executives will hold a webcast at 8:30 a.m. ET the same day to discuss the results. The webcast will be accessible live on Viatris' investor relations website, with a replay available afterward. Investors and the public can also join via phone at 844.308.3344 or 412.317.1896 for international callers.

Positive
  • Announcement of Q2 2024 results date provides clarity on financial performance timing.
  • CEO Scott A. Smith and executives will discuss results, indicating transparency and direct communication with investors.
  • Accessibility of the webcast and replay on the investor relations website enhances investor engagement.
Negative
  • No preliminary financial figures or guidance provided ahead of the results announcement.
  • Lack of specific details on expected performance could create uncertainty among investors.

PITTSBURGH, June 7, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report its second quarter 2024 financial results on Thursday, August 8, 2024, before the open of the U.S. financial markets. Chief Executive Officer Scott A. Smith and other Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.

Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.

About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India.  Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X (formerly Twitter).

Viatris OUS Logo (PRNewsfoto/Viatris Inc.)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-report-second-quarter-2024-financial-results-on-august-8-2024-302166626.html

SOURCE Viatris Inc.

FAQ

When will Viatris report its second quarter 2024 financial results?

Viatris will report its second quarter 2024 financial results on August 8, 2024.

What is the stock symbol for Viatris?

The stock symbol for Viatris is VTRS.

Who will discuss Viatris' Q2 2024 financial results?

CEO Scott A. Smith and other executives will discuss the Q2 2024 financial results.

How can investors listen to Viatris' Q2 2024 results webcast?

Investors can listen to the live webcast on Viatris' investor relations website or by calling 844.308.3344 (domestic) and 412.317.1896 (international).

Will there be a replay available for Viatris' Q2 2024 financial results webcast?

Yes, a replay of the webcast will be available on Viatris' investor relations website.

Viatris Inc.

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Stock Data

14.66B
1.19B
0.41%
82.85%
1.74%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
CANONSBURG